A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome.
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome.
M. Ciampelli,F. Leoni,3 Authors,A. Lanzone
2002 · DOI: 10.1093/HUMREP/17.3.647
Human Reproduction · 10 Citations
TLDR
Acipimox does not appear to be an effective insulin-lowering drug in PCOS, even if it can be used in obese women with PCOS as an additional therapeutic agent to ameliorate the atherogenic lipid profile of the syndrome.
